Literature DB >> 28012489

Pathognomonic remodeling of blood and lymphatic capillaries in idiopathic pulmonary fibrosis.

Masahito Ebina1.   

Abstract

Numerous studies have been published investigating the pathologic alterations in various interstitial pneumonias, particularly in idiopathic pulmonary fibrosis (IPF). However, the few existing studies on capillary remodeling, which does not seem to have priority for pathologic diagnosis, are contradictory, with some reporting increased and others reduced vascularization. We hypothesized that these discrepancies were due to the temporal heterogeneity of the lesions in IPF. We subsequently developed original techniques for evaluating vascular density within the alveolar septa and discovered, for the first time, a heterogeneous increase in alveolar capillaries in the lungs of IPF patients. Notably, we consistently found that the fibrotic lesions in IPF lungs, which are composed mainly of dense collagen with myofibroblasts, featured a reduction in capillaries. This finding provides a plausible explanation for the intractability of IPF, as this reduced vascularization would result in poor delivery of anti-fibrotic agents to these lesions. We also reported the disappearance of subpleural and interlobular lymphatics in IPF lungs, which likely results in poor alveolar clearance in the diseased lungs. Finally, we assessed the autopsied lungs of patients with IPF who died because of acute exacerbation and observed increased and dilated alveolar capillaries. These capillaries are likely to be "leaky" owing to exposure to VEGF produced by regenerated alveolar type II epithelial cells. Furthermore, poor alveolar clearance may prolong the high mobility group box 1 (HMGB1)-induced lung injury in acute exacerbation of IPF. Our data obtained from the assessment of blood and lymphatic capillary alterations in IPF provide novel pathogenetic insights and may provide the basis for new therapeutic strategies targeting IPF.
Copyright © 2016 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alveolar septa; Interlobular septa; Myofibroblast; Pulmonary lobule; Usual interstitial pneumonia

Mesh:

Year:  2016        PMID: 28012489     DOI: 10.1016/j.resinv.2016.08.005

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  4 in total

1.  Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury.

Authors:  Peter Baluk; Ram P Naikawadi; Shineui Kim; Felipe Rodriguez; Dongwon Choi; Young-Kwon Hong; Paul J Wolters; Donald M McDonald
Journal:  Am J Pathol       Date:  2020-10-08       Impact factor: 4.307

2.  Buyang Huanwu Tang inhibits cellular epithelial-to-mesenchymal transition by inhibiting TGF-β1 activation of PI3K/Akt signaling pathway in pulmonary fibrosis model in vitro.

Authors:  Zi-Fei Yin; Yang-Lin Wei; Xuan Wang; Li-Na Wang; Xia Li
Journal:  BMC Complement Med Ther       Date:  2020-01-15

Review 3.  Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis.

Authors:  Jincheng Wang; Kaili Hu; Xuanyan Cai; Bo Yang; Qiaojun He; Jiajia Wang; Qinjie Weng
Journal:  Acta Pharm Sin B       Date:  2021-07-29       Impact factor: 11.413

4.  Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis.

Authors:  Taylor S Adams; Jonas C Schupp; Sergio Poli; Ehab A Ayaub; Nir Neumark; Farida Ahangari; Sarah G Chu; Benjamin A Raby; Giuseppe DeIuliis; Michael Januszyk; Qiaonan Duan; Heather A Arnett; Asim Siddiqui; George R Washko; Robert Homer; Xiting Yan; Ivan O Rosas; Naftali Kaminski
Journal:  Sci Adv       Date:  2020-07-08       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.